prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype LumA, SPECIMEN: Sex: F. Date Collected: Date Received: Clinical History/Diagnosis: Right Breast CA. Source of Specimen(s): 1: Sentinel nodes right axilla. 2: Right breast lumpectomy. 3: Final posterior margin (pectoral margin). 4: Final anterior and medial margin. Gross Description: Received in four parts. Source of Tissue: 1. Labeled #1, "sentinel node right axilla". Touch Preparation/Frozen Section Evaluation: TOUCH PREP NO TUMOR SEEN,. FROZEN SECTION NO TUMOR SEEN PER. Gross Description: Received fresh for touch preparation/frozen section. evaluation labeled "sentinel node right axilla" are two tan focally blue dye stained firm. lymph nodes, 2.0 cm in greatest dimension. They are sectioned, touch preparations are. made and frozen sections are performed on each lymph node. The frozen section. residues are submitted in two blocks. The remaining lymph node tissue is. entirely submitted in four blocks. Designation of Sections: 1FSA- frozen section lymph node A, 1FSB- frozen. section lymph node B, 1A-1B- 1TPA, 1C-1D- 1TPB. Summary of Sections: multiple. Source of Tissue: 2. Labeled #2, "right breast lumpectomy". Gross Description: Received fresh labeled "right breast lumpectomy" is a 9.0 x 7.5 x 4.5. cm yellow-tan fragment of breast tissue. It is covered in part by a 5.0 x 2.5 cm light-tan. skin ellipse. There is a short stitch denoting the superior margin and a long. stitch denoting the lateral margin. The margins are inked in black, the. specimen is serially sectioned to reveal predominantly yellow-tan adipose. tissue. There is an ill-defined, 3.0 x 2.5 x 1.6 cm firm mass having tan. gritty cut surfaces with infiltrating borders. This grossly appears to. come closest to the inked anterior, posterior and medial margins. Representative sections are submitted in ten blocks. Designation of Sections: 2A- superior, 2B- inferior, 2C-2D- medial, 2E-. lateral, 2F-2H- anterior, 2I-2J- posterior. Summary of Sections: multiple. Source of Tissue: 3. Labeled #3, "final posterior margin (pectoral. margin)". Gross Description: Received fresh labeled "final posterior margin (pectoral margin)" is a. 2.2 x 1.0 x 0.4 cm red-purple fragment of soft tissue and muscle. There is a stitch present. marking the final margin and this area is inked in black. The specimen is. sectioned and entirely submitted in one block. Designation of Sections: Block 3. Summary of Sections: undesignated-multiple. Source of Tissue: 4. Labeled #4, "final anterior and medial margin". Gross Description: Received fresh labeled "final anterior and medial margin" is a 6.0 x. 0.6 cm tan elliptical fragment of skin excised to a depth of 0.4 cm. The margins are. inked in black, it is serially sectioned and entirely submitted in two blocks. Designation of Sections: 4A-4B. Summary of Sections: multiple. Final Diagnosis: 1. Right axilla, sentinel lymph nodes, excision: - Two lymph nodes with no tumor seen (0/2), see note. Note: Immunohistochemical stains for Cytokeratin will be reported as an. addendum. 2. Right breast, lumpectomy:- Invasive lobular carcinoma, grade II with. microscopic focus of pleomorphic changes (3.0 cm); lymphovascular invasion. is not seen. - Invasive carcinoma extends to the inked and cauterized lateral and inked. anterior breast parenchymal margin; approximately 2.0 mm from the inked. posterior margin. - Focal atypical ductal hyperplasia approximately 1.0 mm from inked. superior margin. 3. Final posterior margin: - Fibroadipose tissue and skeletal muscle, no tumor seen. 4. Final anterior and medial margin: - Skin and subcutaneous tissue, no tumor seen. (pT2 NO Mx). Pathology Fellow: Pathologist(s): Procedures/Addenda. Addendum Date Ordered: Date Complete: Addendum Diagnosis. Immunohistochemistry stains for the sentinel lymph nodes (specimen #1) do. not reveal metastatic carcinoma, comfirming the histologic diagnosis. These tests were developed and their performance characteristics. determined by the immunohistochemistry laboratory at the. These tests have not been cleared or approved by the U.S. Food. and Drug Administration. The FDA has determined that such clearance or. approval is not necessary. These tests are used for clinical purposes. They should not be regarded as investigational or for research. This. laboratory is certified under the Clinical Laboratory Improvement. Amendments of 1998 (CLIA) as qualified to perform high complexity clinical. testing. INVASIVE BREAST CANCER TEMPLATE: Excisions and Mastectomies. Specimen Type. Excision. Lymph Node Sampling. Sentinel lymph node(s) only. Specimen Size (for excisions less than total mastectomy). Greatest dimension:9.0 cm. Laterality. Right. Tumor Site(s). Not specified. Invasive Component. Solitary. Greatest dimension: 3.0 cm. Histologic Type(s). Invasive lobular. Invasive Lobular Carcinoma Type. Classical Solid Trabecular and Pleomorphic. Invasion. Invasion confined to breast parenchyma. Angiolymphatic Invasion. Absent. Intraductal Carcinoma. Extensive intraductal component (EIC) [>25% of tumor mass and. extending beyond edges of invasive carcinoma]. Absent. Lobular carcinoma in situ. Absent. Margins. Margin(s) involved by invasive carcinoma: lateral. Regional Lymph Nodes. 2 regional lymph nodes examined. No regional lymph node metastasis histologically, no examination for. isolated tumor cells (NO). Ancillary Immunopathology Studies (performed on. ER. Positive. PR. Negative. Her2-Neu. 1+. pTNM: T2 NO Mx.

expanded version (tokens=1743) : 
 Histological classification: The histological classification of the breast pathology report is Luminal A subtype.

Subtype: The subtype of the breast cancer is Luminal A.

Description of necrosis: The breast pathology report doesn't mention any description of necrosis.

Tumor infiltrating lymphocytes: The report doesn't mention the presence or absence of tumor-infiltrating lymphocytes.

Histological grade: The histological grade of the invasive carcinoma is grade II.

Nuclear grade: The nuclear grade of the invasive carcinoma has not been mentioned in the report.

Lymphovascular invasion: The report mentions that lymphovascular invasion is not seen.

Calcification: The report doesn't mention the presence or absence of calcifications.

Receptor status: The immunopathology studies reveal that the ER is positive, PR is negative, and Her2-Neu is 1+.

Ancillary testing results: The report mentions that immunohistochemistry stains for cytokeratin will be reported as an addendum. The report also mentions that the tests were developed and their performance characteristics determined by the immunohistochemistry laboratory at the institution. These tests have not been cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary.

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=1895) : 
 The breast pathology report shows Luminal A subtype invasive lobular carcinoma with a grade II histological grade. No tumor is seen in the sentinel lymph nodes, while lymphovascular invasion is not detected. ER is positive, PR is negative, and Her2-Neu is 1+. There is a microscopic focus of pleomorphic changes extending to the inked anterior and lateral margins. Focal atypical ductal hyperplasia is also noted. Immunohistochemistry stains for cytokeratin will be reported separately.

